1,3,5-trisubstituted 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activity

Details for Australian Patent Application No. 2005210163 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Lange, Josephus H.M.; Van Stuivenberg, Herman H.; Kruse, Cornelis G.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005210163

PCT Pub. Number WO2005/074920

Priority 04100338.5 30.01.04 EP; 60/539,983 30.01.04 US

Filing date 27 January 2005

Wipo publication date 18 August 2005

Acceptance publication date 13 May 2010

International Classifications

C07D 231/06 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/074920 Priority application(s): WO2005/074920

13 May 2010 Application Accepted

  Published as AU-B-2005210163

9 September 2010 Standard Patent Sealed

23 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210164-Heat-exchanger for carrying out an exothermic reaction

2005210155-Spool and spool assembly for windingup carrier tapes of a packaging taped imbricated bag chain